Induction of vascular smooth muscle cell expression of plasminogen activator inhibitor-1 by thrombin.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Circulation Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.RES.72.1.36PMID 8417845
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thrombin Specificity

  1995cited by this paper
• Synergistic induction of plasminogen activator inhibitor type-1 in HEP G2 cells by thrombin and transforming growth factor-beta.

  1992cited by this paper
• A Decrease in Plasminogen Activator Inhibitor-1 Activity after Successful Percutaneous Transluminal Coronary Angioplasty Is Associated with a Significantly Reduced Risk for Coronary Restenosis

  1992cited by this paper
• Augmented arterial wall expression of type-1 plasminogen activator inhibitor induced by thrombosis.

  1992cited by this paper
• Regulation of PAI-1 gene expression

  1991cited by this paper
• Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF

  1991cited by this paper
• Mechanisms contributing to increased synthesis of plasminogen activator inhibitor type 1 in endothelial cells by constituents of platelets and their implications for thrombolysis.

  1991cited by this paper
• Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells.

  1991cited by this paper
• Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: Implications for vascular disease in hyperinsulinemic states

  1991cited by this paper
• [Type 1 plasminogen activator inhibitor].

  1990cited by this paper
• Thrombin signal transduction mechanisms in rat vascular smooth muscle cells. Calcium and protein kinase C-dependent and -independent pathways.

  1990cited by this paper
• A new adaptation of Coatest® PAI for measurements of low inhibitor concentrations in plasma

  1990cited by this paper
• Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation.

  1990cited by this paper
• Influence of the angiotensin system on endothelial and smooth muscle cell migration.

  1990cited by this paper
• Thrombin regulation of mRNA levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells.

  1989cited by this paper
• Purification of a protein from bovine plasma that binds to type 1 plasminogen activator inhibitor and prevents its interaction with extracellular matrix. Evidence that the protein is vitronectin.

  1989cited by this paper
• Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties.

  1989cited by this paper
• Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle.

  1989cited by this paper
• Potential attenuation of fibrinolysis by growth factors released from platelets and their pharmacologic implications.

  1989cited by this paper
• Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis.

  1989cited by this paper
• Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay.

  1988cited by this paper
• Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity.

  1988cited by this paper
• Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells.

  1987cited by this paper
• A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction.

  1987cited by this paper
• The Interaction of Activated Protein C and Thrombin with the Plasminogen Activator Inhibitor Released from Human Endothelial Cells

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Deficient t-PA Release and Elevated PA Inhibitor Levels in Patients with Spontaneous or Recurrent Deep Venous Thrombosis

  1987cited by this paper
• Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor.

  1987cited by this paper
• Growth inhibition by protein kinase C late in mitogenesis

  1987cited by this paper
• A spectrophotometric solid-phase fibrin-tissue plasminogen activator activity assay (SOFIA-tPA) for high-fibrin-affinity tissue plasminogen activators.

  1986cited by this paper
• Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury.

  1986cited by this paper
• The pathogenesis of atherosclerosis--an update.

  1986cited by this paper
• Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells.

  1986cited by this paper
• Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.

  1985cited by this paper
• Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions.

  1984cited by this paper
• Mechanisms of stenosis after arterial injury.

  1983cited by this paper
• Selective immobilization of alpha-thrombin by surface-bound fibrin.

  1981cited by this paper
• THROMBIN SPECIFICITY *

  1981cited by this paper
• Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

  1980cited by this paper
• Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

  1975cited by this paper
• THE SMOOTH MUSCLE CELL

  1971cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Plasminogen activator inhibitor‐1 regulates the vascular expression of vitronectin

  2017cites this paper
• Genética y biología molecular en cardiología (II) Biología celular y molecular de las lesiones ateroscleróticas

  2016cites this paper
• Expression of plasminogen activator inhibitor‐1 by olfactory ensheathing glia promotes axonal regeneration

  2011cites this paper
• Reciprocal Regulation of Rac1 and PAK-1 by HIF-1α: A Positive-Feedback Loop Promoting Pulmonary Vascular Remodeling

  2010cites this paper
• Inhibition of hypercoagulation by antithrombin substitution in E. coli L‐asparaginase‐treated children

  2009cites this paper
• Animals Models in Restenosis The Pig Restenosis Model

  2008cites this paper
• Rac-1 promotes pulmonary artery smooth muscle cell proliferation by upregulation of plasminogen activator inhibitor-1: Role of NFκB-dependent hypoxia-inducible factor-1α transcription

  2008cites this paper
• Chapte rr 5 Plasminogenn activator inhibitor 1 and vitronectin protect againstt stenosis in a murine carotid artery ligation model

  2007cites this paper
• The serpin protease nexin‐1 regulates vascular smooth muscle cell adhesion, spreading, migration and response to thrombin

  2006cites this paper
• Modulation of protease nexin-1 activity by polysaccharides

  2006cites this paper
• Effects of Tissue Plasminogen Activator and a Comparison of Early Invasive and Conservative Strategies in Unstable Angina and Non-Q-Wave Myocardial Infarction Results of the TIMI IIIB Trial The TIMI IIIB

  2005cites this paper
• Human aortic vascular smooth muscle cells digest extracellular matrix by elaboration of plasminogen activators: Implications for atherogenesis

  2005cites this paper
• Comparison of Early Invasive and Conservative Strategies in Unstable Angina and Non-Q-Wave Myocardial Infarction

  2005cites this paper
• Effects of Tissue Plasminogen Activator and a Comparison of Early Invasive and Conservative Strategies in Unstable Angina and Non-Q-Wave Myocardial Infarction Results of the TIMI IIIB Trial

  2005cites this paper
• Effects of Tissue Plasminogen Activator and a Comparison of Early Invasive and Conservative Strategies in Unstable Angina and Non-Q-Wave Myocardial Infarction Results of the TIMI IIIB Trial

  2005cites this paper
• Effects of Tissue Plasminogen Activator and a Comparison of Early Invasive and Conservative Strategies in Unstable Angina and Non-Q-Wave Myocardial Infarction Results of the TIMI IIIB Trial

  2005cites this paper
• Selective promotion of plasminogen activator inhibitor-1 secretion by activation of proteinase-activated receptor-1 in cultured human brain microvascular pericytes: comparison with endothelial cells.

  2005cites this paper
• Comparison of Early Invasive and Conservative Strategies in Unstable Angina and Non-Q-Wave Myocardial Infarction

  2005cites this paper
• Protease nexin‐1: A cellular serpin down‐regulated by thrombin in rat aortic smooth muscle cells

  2004cites this paper
• Factor V Inhibits Fibrinolysis In Vivo

  2004cites this paper
• Factor VLeiden Inhibits Fibrinolysis In Vivo

  2004cites this paper
• Molecular and cellular basis of restenosis after percutaneous coronary intervention: the intertwining roles of platelets, leukocytes, and the coagulation–fibrinolysis system

  2004cites this paper
• Independence of growth factor induced plasminogen activator inhibitor type-1 (PAI-1) expression from the 4G/5G polymorphism of the PAI-1 gene

  2003cites this paper
• Tissue factor pathway inhibitor production by human proximal tubular epithelial cells in culture.

  2003cites this paper
• Plasminogen Activator Inhibitor 1 and Vitronectin Protect Against Stenosis in a Murine Carotid Artery Ligation Model

  2002cites this paper
• Carotid Artery Ligation Model Plasminogen Activator Inhibitor 1 and Vitronectin Protect Against Stenosis in a Murine

  2002cites this paper
• [Cellular and molecular biology of atherosclerotic lesions].

  2001cites this paper
• Acute Phase Protein α1-Acid Glycoprotein Interacts with Plasminogen Activator Inhibitor Type 1 and Stabilizes Its Inhibitory Activity*

  2001cites this paper
• Attenuation by Fibrates of Plasminogen Activator Inhibitor Type-1 Expression in Human Arterial Smooth Muscle Cells

  2001cites this paper
• In situ Analysis of Tissue Factor-Dependent Thrombin Generation in Human Atherosclerotic Vessels

  2000cites this paper
• Plasmin Activation System in Restenosis: Role in Pathogenesis and Clinical Prediction?

  1999cites this paper
• Transcellular Signaling and Pharmacological Modulation of Thrombin-Induced Production of Plasminogen Activator Inhibitor-1 in Vascular Smooth Muscle Cells

  1998cites this paper
• Cellular and Molecular Effects of Thrombin in the Vascular System

  1998cites this paper
• Oxidative modification enhances lipoprotein(a)-induced overproduction of plasminogen activator inhibitor-1 in cultured vascular endothelial cells.

  1997cites this paper
• Inhibition by hirulog-1 of generation of plasminogen activator inhibitor-1 from vascular smooth-muscle cells induced by thrombin.

  1997cites this paper
• G proteins and phospholipase C mediate thrombin-induced generation of plasminogen activator inhibitor-1 from vascular smooth muscle cells.

  1997cites this paper
• The suicide substrate reaction between plasminogen activator inhibitor 1 and thrombin is regulated by the cofactors vitronectin and heparin.

  1997cites this paper
• Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis.

  1997cites this paper
• Molecular advances in plasminogen activator inhibitor 1 interaction with thrombin and tissue-type plasminogen activator.

  1997cites this paper
• Effect of notoginsenoside R1 on the synthesis of components of the fibrinolytic system in cultured smooth muscle cells of human pulmonary artery.

  1997cites this paper
• Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells.

  1997cites this paper
• Effect of endothelin on the regulation of the fibrinolytic system of cultured human vascular smooth muscle cells

  1997cites this paper
• Review article Haemostatic factors and atherogenesis

  1996cites this paper
• Receptor-mediated effect of thrombin on plasminogen activator inhibitor-1 synthesis in rat osteoblast-like cells

  1996cites this paper
• Haemostatic factors and atherogenesis.

  1996cites this paper
• Restenosis—an open file

  1996cites this paper
• Inhibitory effect of a new butadiene derivative on the production of plasminogen activator inhibitor-1 in cultured bovine endothelial cells.

  1996cites this paper
• Thrombin Modulation of Plasminogen Activator Inhibitor-1 (PAI-1) in Cultured Human Vascular Smooth Muscle Cells

  1996cites this paper
• The role of thrombin in coronary artery thrombosis.

  1996cites this paper
• Gene Therapy for Thrombotic Diseases

  1995cites this paper
• Regulation of smooth muscle cell proliferation and its possible role in preventing restenosis post-angioplasty.

  1995cites this paper
• The Three Processes Leading to Post PTCA Restenosis: Dependence on the Lesion Substrate

  1995cites this paper
• Regulation of plasminogen activator inhibitor type 1 in cultured smooth muscle cells by interleukin 1α and tumour necrosis factor-α

  1995cites this paper
• Importance of platelets in the process leading to PAI-1 increase following endotoxaemia in vivo

  1995cites this paper
• Vascular smooth muscle cell migration mediated by thrombin and urokinase receptor.

  1995cites this paper
• Physiological consequences of over- or under-expression of fibrinolytic system components in transgenic mice.

  1995cites this paper
• Effect of thrombin on release of plasminogen activator inhibitor-1 from cultured primate arterial smooth muscle cells.

  1995cites this paper
• Role of the thrombin receptor in restenosis and atherosclerosis.

  1995cites this paper
• Role of the plasminogen/plasmin system in thrombosis, hemostasis, restenosis and atherosclerosis evaluation in transgenic animals.

  1995cites this paper
• Augmented urokinase receptor expression in atheroma.

  1995cites this paper
• Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.

  1994cites this paper
• Stimulation of PAI-1 expression in endothelial cells by cultured vascular smooth muscle cells.

  1994cites this paper
• Increased intramural expression of plasminogen activator inhibitor type 1 after balloon injury: a potential progenitor of restenosis.

  1994cites this paper
• Angiotensin II Increases Plasminogen Activator Inhibitor Type 1 and Tissue‐Type Plasminogen Activator Messenger RNA in Cultured Rat Aortic Smooth Muscle Cells

  1994cites this paper
• Stimulation of migration of human aortic smooth muscle cells by vitronectin: implications for atherosclerosis.

  1994cites this paper
• Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI IIIB trial: The TIMI IIIB Investigators Circulation 89:1545–1556 Apr 1994

  1994cites this paper
• Fibrin as a factor in atherogenesis.

  1994cites this paper
• Inhibition of type-1 plasminogen activator inhibitor production by antisense oligonucleotides in human vascular endothelial and smooth muscle cells.

  1994cites this paper